CNTB
$2.71
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States.
Recent News
Connect Biopharma Touts “Next-Gen Dupixent” Rademikibart, Near-Term Asthma/COPD Readouts
Connect Biopharma (NASDAQ:CNTB) CEO Barry Quart outlined the company’s focus on rademikibart, an IL-4 receptor alpha monoclonal antibody he described as a “next-generation DUPIXENT,” during a presentation at the Leerink Partners Global Healthcare Conference. Quart emphasized both chronic and acute-c
Connect Biopharma Touts Rademikibart as Fast-Acting Option for Acute Asthma, COPD Flare-Ups at Conference
Connect Biopharma (NASDAQ:CNTB) CEO Barry Quart told investors at Oppenheimer’s 36th Annual Healthcare Life Science Conference that the company is advancing its lead asset, rademikibart, into what it described as a novel treatment approach for acute exacerbations of asthma and chronic obstructive pu
3 Promising Penny Stocks With Market Caps Up To $400M
Major stock indexes saw a significant rebound recently, with the Dow Jones adding 450 points after President Trump ruled out the use of force in Greenland. Amidst this backdrop of market volatility and geopolitical tensions, investors are exploring opportunities beyond traditional stocks. Penny stocks, often representing smaller or newer companies, continue to attract attention for their potential value and growth prospects. In this article, we explore three penny stocks that showcase...
Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks
As the U.S. stock market continues to rally, with major indexes like the S&P 500 and Dow Jones nearing record highs, investors are increasingly looking for opportunities in less traditional areas. Penny stocks, though often considered a relic of past market trends, remain a compelling option for those seeking growth potential at lower price points. These stocks typically represent smaller or newer companies and can offer significant upside when backed by strong financial health and solid...
Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 39% ownership, individual investors own 22%
Key Insights Connect Biopharma Holdings' significant private equity firms ownership suggests that the key decisions are...